| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), DCOY's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 34.8K | - | - | |
| CFO | 11.4K | - | - | |
| Other | 4.2K | - | - | |
| Other | 3.9K | - | - | |
| Dir | 3.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2022 | Arthur David J. | Chief Executive Officer | Buy | 139,488 | $0.39 | $54,539.81 | +126.6% | -54.7% | -77.8% | |
| Aug 17, 2021 | Arthur David J. | Chief Executive Officer | Buy | 4,000 | $0.90 | $3,582.00 | +4.1% | -13.4% | -73.7% | |
| Aug 10, 2021 | Hanish Arnold C46 | - | Buy | 7,000 | $0.88 | $6,167.00 | +61.7% | -6.3% | -72.5% | |
| Aug 21, 2020 | Hanish Arnold C46 | - | Buy | 4,000 | $0.98 | $3,920.00 | +54.4% | - | - | |
| Aug 19, 2020 | Arthur David J. | Chief Executive Officer | Buy | 2,000 | $1.01 | $2,020.00 | New | - | - | |
| Aug 17, 2020 | Rosenblum Mark J | Executive VP Finance, CFO | Buy | 5,000 | $1.00 | $5,000.00 | +71.4% | - | - | |
| Feb 19, 2020 | Rosenblum Mark J | Executive VP Finance, CFO | Buy | 2,000 | $0.95 | $1,900.00 | +40.0% | - | - | |
| Feb 18, 2020 | Jordan Scott | Chief Business Officer | Buy | 11,300 | $0.90 | $10,170.00 | +55.6% | - | - | |
| Feb 13, 2020 | Rosenblum Mark J | Executive VP Finance, CFO | Buy | 5,000 | $0.86 | $4,295.00 | New | - | - | |
| Feb 11, 2020 | McVicar William K. | Director | Buy | 8,700 | $1.15 | $10,005.00 | New | - | - |